Biliary Malignant Tumors
2 clinical trials · Condition
◉ Watch Biliary Malignant Tumors
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection (NCT07368803) | Yifan Wang | 2025-09-11 |
| Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk (NCT06685289) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-15 |
Track Biliary Malignant Tumors automatically
Every clearance here is in the API, with alerts when new ones post.